Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) — Stella
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations(6 sites)
France
Institut Bergonie, Bordeaux
Centre Oscar Lambret, Lille
Centre Leon Berard, Lyon
Institut Curie, Paris
Institut Curie Hopital Rene Huguenin, Saint-Cloud
Institut de Cancérologie de Lorraine - Nancy, Vandœuvre-lès-Nancy